Viyash Scientific Limited
Edelweiss Mutual Fund bought 2,592,600 shares of Viyash Scientific Limited for ₹70.00 Cr at ₹270.00 apiece in a block deal.
A leading animal health company headquartered in India, this organization develops and manufactures finished dose formulations, active pharmaceutical ingredients, and analytical services for the pharmaceutical and life sciences sectors. Operating across more than 100 countries spanning five continents, the company serves veterinary and industrial clients globally with a comprehensive product portfolio designed for animal health applications and therapeutic solutions.
AMC subsidiary of Edelweiss Financial Services. Manages over Rs 1.5 lakh crore across equity, debt, hybrid and alternative strategies. CEO Radhika Gupta is the most prominent woman leader in Indian asset management and has built a strong direct investor franchise through social media and investor education. Known for multi-asset and international fund-of-fund offerings.